Despite the fact that many types of cancer very well to care, very often the threat of the disease returning in the form of relapses, to identify and predict which is not always easy. However, medicine is not in place and was recently presented a new method of analyzing blood, which will allow oncologists to accurately know about the likelihood of tumor recurrence and effectiveness of treatment.
For the development of a method meets a group of researchers from the UK and it is called “liquid biopsy”. The study involved a group of patients with metastatic colorectal cancer. They have over a long period of time took the analysis an extended analysis of the blood for the presence of tumor markers and their predecessors. In the end it turned out that some of the patients were refractory to primary chemotherapy drug for the treatment of colorectal cancer. Moreover, 75% of patients who initially responded positively to treatment method liquid biopsy revealed a relapse of the cancer faster and better than conventional survey methods.
As reported by experts, a new method of diagnosis does not negate your existing strategy examination and diagnostics like imaging, CT, MRI and so forth, but it can be used in addition to them. After all, according to the data obtained if the liquid biopsy every 2-4 weeks, this will give the opportunity not only to monitor the effectiveness of existing therapies, but also to adjust the treatment, the dosage of the medications, change regimens of drugs depending on susceptibility of the organism, and also successfully predict the probability of tumor recurrence.
What do you think about the new way? Tell us about it in our telegram chat.
A new blood test will help to know about the risk of cancer recurrence
Vladimir Kuznetsov